A股異動 | 遠大控股(000626.SZ)漲超5% 擬定增募資不超6億元
格隆匯5月13日丨遠大控股(000626.SZ)盤中衝高漲約6.7%後小幅回落,現報18.16元,漲幅5.4%,最新總市值92.4億。公司昨日公吿稱,擬非公開發行不超過4325.8萬股(含本數),募集資金總額不超過6億元(含本數),扣除發行費用後,2.9億元用於收購凱立生物85.1166%股權,1.4億元用於收購遼寧微科100%股權,1.7億元用於補充流動資金。此次發行為非公開發行,發行對象為公司實際控制人胡凱軍控制的公司遠大產融。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.